In this review:
Histologies in varying HCV undetectability durations after IFN
High-dose pegIFN-alpha-2a induction: final
CHARIOT results
AlbIFN-alpha-2b plus ribavirin in genotype 2 or 3 chronic HCV
Telaprevir in genotype 1 HCV: results from PROVE3
Bezafibrate in PBC pa
Please login below to download this issue (PDF)